The Summer 2014 issue of Viewpoints highlights a promising study from the University of Saskatchewan on Caffeitine, a hybrid drug combining caffeine and nicotine, which may help prevent the misfolding of alpha-synuclein, a protein linked to Parkinson's disease. The...
Viewpoints: Summer 2014
read more